Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3864)
All Articles published online
|
Jun 21, 2012 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Qu JH, Chang XJ, Lu YY, Bai WL, Chen Y, Zhou L, Zeng Z, Wang CP, An LJ, Hao LY, Xu GL, Gao XD, Lou M, Lv JY, Yang YP. Overexpression of metastasis-associated in colon cancer 1 predicts a poor outcome of hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2012; 18(23): 2995-3003 [PMID: 22736924 DOI: 10.3748/wjg.v18.i23.2995] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i23/2995.htm |
| Number | Citing Articles |
| 1 |
He Li, Yi-Xin Chen, Jia-Gen Wen, Hong-Hao Zhou. Metastasis-associated in colon cancer 1: A promising biomarker for the metastasis and prognosis of colorectal cancer. Oncology Letters 2017; 14(4): 3899 doi: 10.3892/ol.2017.6670
|
| 2 |
Li-Qiang Qian, Xia-Qin Li, Peng-Hui Ye, Hao-Yuan Su, Gang Wang, Yan Liu, Gen-Hai Shen, Quan-Gen Gao. Downregulation of MACC1 inhibits the viability, invasion and migration and induces apoptosis in esophageal carcinoma cells through the phosphatase and tensin homolog/phosphoinositide 3-kinase/protein kinase B signaling pathway. Oncology Letters 2017; 14(4): 4897 doi: 10.3892/ol.2017.6790
|
| 3 |
Andri Lederer, Pia Herrmann, Daniel Seehofer, Manfred Dietel, Johann Pratschke, Peter Schlag, Ulrike Stein. Metastasis‐associated in colon cancer 1 is an independent prognostic biomarker for survival in klatskin tumor patients. Hepatology 2015; 62(3): 841 doi: 10.1002/hep.27885
|
| 4 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3399 doi: 10.1007/978-3-319-26956-6_184
|
| 5 |
Yong-Ping Yang, Jian-Hui Qu, Xiu-Juan Chang, Yin-Ying Lu, Wen-Lin Bai, Zheng Dong, Hong Wang, Lin-Jing An, Zhong-Xian Xu, Chun-Ping Wang, Zhen Zeng, Ke-Qin Hu. High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma. Journal of Translational Medicine 2013; 11(1) doi: 10.1186/1479-5876-11-41
|
| 6 |
HAI-FENG LI, YE-QING LIU, ZHUO-JIAN SHEN, XIANG-FENG GAN, JING-JING HAN, YUN-YUN LIU, HAI-GANG LI, ZHI-QUAN HUANG. Downregulation of MACC1 inhibits invasion, migration and proliferation, attenuates cisplatin resistance and induces apoptosis in tongue squamous cell carcinoma. Oncology Reports 2015; 33(2): 561 doi: 10.3892/or.2014.3612
|
| 7 |
Hailong Hu, Dawei Tian, Tao Chen, Ruifa Han, Yan Sun, Changli Wu, William B. Coleman. Metastasis-Associated in Colon Cancer 1 Is a Novel Survival-Related Biomarker for Human Patients with Renal Pelvis Carcinoma. PLoS ONE 2014; 9(6): e100161 doi: 10.1371/journal.pone.0100161
|
| 8 |
Xianglian Zhang, Ya Luo, Yu Cen, Xin Qiu, Jing Li, Mengmeng Jie, Shiming Yang, Shanyu Qin. MACC1 promotes pancreatic cancer metastasis by interacting with the EMT regulator SNAI1. Cell Death & Disease 2022; 13(11) doi: 10.1038/s41419-022-05285-8
|
| 9 |
Ke-Qin Hu. Advances in Clinical Application of Cryoablation Therapy for Hepatocellular Carcinoma and Metastatic Liver Tumor. Journal of Clinical Gastroenterology 2014; 48(10): 830 doi: 10.1097/MCG.0000000000000201
|
| 10 |
Inti Zlobec. Novel biomarkers for the prediction of metastasis in colorectal cancer. Expert Opinion on Medical Diagnostics 2013; 7(2): 137 doi: 10.1517/17530059.2013.753054
|
| 11 |
Haifeng Li, Xiaoying Liao, Yeqing Liu, Zhuojian Shen, Xiangfeng Gan, Haigang Li, Zhiquan Huang. The expression of MACC1 and its role in the proliferation and apoptosis of salivary adenoid cystic carcinoma. Journal of Oral Pathology & Medicine 2015; 44(10): 810 doi: 10.1111/jop.12309
|
| 12 |
Mohsen Mohammadi, Peyman Karimi Goudarzi, Omid Rahmani, Peyman Kaghazian, Emad Yahaghi, Afshin Taheriazam, Koroosh Ahmadi. RETRACTED ARTICLE: Evaluation of gene expression level of CDC5L and MACC1 in poor prognosis and progression of osteosarcoma. Tumor Biology 2016; 37(6): 8153 doi: 10.1007/s13277-015-4726-y
|
| 13 |
Kai Zhang, Yonggang Zhang, Huimin Zhu, Na Xue, Jie Liu, Chao Shan, Qing Zhu. High expression of MACC1 predicts poor prognosis in patients with osteosarcoma. Tumor Biology 2014; 35(2): 1343 doi: 10.1007/s13277-013-1180-6
|
| 14 |
Zhi-Jun Dai, Xing-Han Liu, Hua-Feng Kang, Xi-Jing Wang, Tian-Bo Jin, Shu-Qun Zhang, Tian Feng, Xiao-Bin Ma, Meng Wang, Yan-Jing Feng, Kang Liu, Peng Xu, Hai-Tao Guan. Genetic Variation in Metastasis-Associated in Colon Cancer-1 and the Risk of Breast Cancer Among the Chinese Han Population. Medicine 2016; 95(6): e2801 doi: 10.1097/MD.0000000000002801
|
| 15 |
Zhenzhen Wu, Rui Zhou, Yuqi Su, Li Sun, Yulin Liao, Wangjun Liao. Prognostic Value of MACC1 in Digestive System Neoplasms: A Systematic Review and Meta-Analysis. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/252043
|
| 16 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_184-1
|
| 17 |
Kai Zhang, Fang Tian, Yonggang Zhang, Qing Zhu, Na Xue, Huimin Zhu, Heng Wang, Xinjun Guo. MACC1 is involved in the regulation of proliferation, colony formation, invasion ability, cell cycle distribution, apoptosis and tumorigenicity by altering Akt signaling pathway in human osteosarcoma. Tumor Biology 2014; 35(3): 2537 doi: 10.1007/s13277-013-1335-5
|
| 18 |
Claudio Isella, Alfredo Mellano, Francesco Galimi, Consalvo Petti, Lorenzo Capussotti, Michele De Simone, Andrea Bertotti, Enzo Medico, Andrea Muratore. MACC1 mRNA Levels Predict Cancer Recurrence After Resection of Colorectal Cancer Liver Metastases. Annals of Surgery 2013; 257(6): 1089 doi: 10.1097/SLA.0b013e31828f96bc
|
| 19 |
Young Wha Koh, Hoon Hur, Dakeun Lee. Increased MACC1 expression indicates a poor prognosis independent of MET expression in gastric adenocarcinoma. Pathology - Research and Practice 2016; 212(2): 93 doi: 10.1016/j.prp.2015.11.018
|
| 20 |
Ziming He, Di Tang. Perioperative predictors of outcome of hepatectomy for HBV-related hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1230164
|
| 21 |
Clara Lemos, Markus S. Hardt, Manisha Juneja, Cynthia Voss, Susann Förster, Boris Jerchow, Wolfram Haider, Hendrik Bläker, Ulrike Stein. MACC1 Induces Tumor Progression in Transgenic Mice and Colorectal Cancer Patients via Increased Pluripotency Markers Nanog and Oct4. Clinical Cancer Research 2016; 22(11): 2812 doi: 10.1158/1078-0432.CCR-15-1425
|
| 22 |
Jian Wu, Dawei Zhang, Jun Li, Xin Deng, Guannan Liang, Yang Long, Xuemei He, Tianyang Dai, Delian Ren. MACC1 induces autophagy to regulate proliferation, apoptosis, migration and invasion of squamous cell carcinoma. Oncology Reports 2017; 38(4): 2369 doi: 10.3892/or.2017.5889
|
| 23 |
Gang Wang, Zhixuan Fu, Dechuan Li. MACC1 overexpression and survival in solid tumors: a meta-analysis. Tumor Biology 2015; 36(2): 1055 doi: 10.1007/s13277-014-2736-9
|
| 24 |
Jie Gao, Feihu Ding, Qingguang Liu, Yingmin Yao. Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9. Molecular and Cellular Biochemistry 2013; 376(1-2): 21 doi: 10.1007/s11010-012-1545-y
|
| 25 |
Ulrike Stein. MACC1 – a novel target for solid cancers. Expert Opinion on Therapeutic Targets 2013; 17(9): 1039 doi: 10.1517/14728222.2013.815727
|
| 26 |
Xi Chen, Bo Li, Wei He, Yong-Gang Wei, Zheng-Gui Du, Li Jiang. Mesohepatectomy versus extended hemihepatectomy for centrally located hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International 2014; 13(3): 264 doi: 10.1016/S1499-3872(14)60253-8
|